๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex

โœ Scribed by S Moteki; PS Leung; ER Dickson; DH Van Thiel; C Galperin; T Buch; D Alarcon-Segovia; D Kershenobich; K Kawano; RL Coppel; S Matuda; ME Gershwin


Book ID
118686129
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
468 KB
Volume
23
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Epitope mapping and reactivity of autoan
โœ S Moteki; P S Leung; E R Dickson; D H Van Thiel; C Galperin; T Buch; D Alarcon-S ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 464 KB ๐Ÿ‘ 1 views

tained reactivity toward PDC-E2 and/or BCOADC-E2. Five different target mitochondrial autoantigens rec-Furthermore, affinity-purified PBC sera against recomognized by sera from patients with primary biliary cirbinant OGDC-E2 reacted only with native OGDC-E2 and rhosis (PBC) have been identified as s

Autoantibody against dihydrolipoamide de
โœ Takashi Maeda; Bruce E. Loveland; Merrill J. Rowley; Dr. Ian R. Mackay ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 717 KB

Autoantibodies in primary biliary cirrhosis recognize mitochondrial 2-oxacid dehydrogenase complexes, particularly the E2 subunits. Reactivity with the E3 subunit, common to each of the enzyme complexes, was sought by immunoblotting, with sera screened at 1:100 instead of the conventional 1:1,000 di

Autoantibodies in primary biliary cirrho
โœ Shelley P. M. Fussey; J. Gordon Lindsay; Christopher Fuller; Richard N. Perham; ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 881 KB

S i x components of the mammalian 2-0x0 acid dehydrogenase complexes have previously been identified as M2 autoantigens in primary biliary cirrhosis. In this report, we present data showing that both polypeptidespecific and cross-reacting antibodies are present in patients' sera. Antibodies reacting